District of Columbia Mesothelioma Fact Sheet
While mesothelioma is a problem in all states, the specific incident rate for District of Columbia is / 100,000. This is below the average rate of 1.1 / 100,000. Click on the tabs below to find mesothelioma and asbestos research in DC, recent DC mesothelioma-related court cases, mesothelioma specialists in DC and potential asbestos hotspots in District of Columbia.
District of Columbia Mesothelioma Info
By clicking on the above tabs, you will find information on mesothelioma specific to the state of District of Columbia
District of Columbia Research and Clinical Trials
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
District of Columbia Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
District of Columbia Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
District of Columbia Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
District of Columbia Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
Wash. Hosp. Ctr. v. D.C. Dep't of Empl. Servs.
No. 03-AA-822 , DISTRICT OF COLUMBIA COURT OF APPEALS, September 1, 2004, Argued , October 7, 2004, Decided
No. 03-AA-822 , DISTRICT OF COLUMBIA COURT OF APPEALS, September 1, 2004, Argued , October 7, 2004, Decided
Hospitals and Cancer Centers
Walter Reed Army Medical Center: Hematology/Oncology Ward 78
6900 General Ave NW
Washington , DC
202.782.6751
Walter Reed Army Medical Center: Hematology/Oncology Ward 78
6900 General Ave NW
Washington , DC
202.782.6751
| City | Site |
| Washington |
National Bureau of Standard |
Research
Clinical Trials
Active, not recruiting Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: dasatinib; Other: immunoenzyme technique; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
More Information
Intervention: Drug: dasatinib; Other: immunoenzyme technique; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
More Information
Condition: Ovarian; Melanoma; Renal; Prostate; Colorectal; Endometrial Carcinoma; Cervical Carcinoma; Testicular Cancer; Thyroid Cancer; Small Cell Lung Carcinoma; Mesothelioma; Breast Carcinoma; Esophageal Carcinoma; Gastric Cancer; Pancreatic Carcinoma; Neuroendocrine Cancer; Liver Cancer; Gallbladder Cancer; Biliary Tract Cancer; Anal Carcinoma; Bone Sarcomas; Soft Tissue Sarcomas; Carcinoma of Unknown Origin, Primary
Intervention: Biological: PSMA/PRAME
More Information
Intervention: Biological: PSMA/PRAME
More Information
